Introduction {#sec1}
============

Human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) ([@bib40]), collectively referred to as human pluripotent stem cells (hPSCs), are currently used in disease modeling to address questions specific to humans and to complement insights gained from other model organisms ([@bib36; @bib37]). Genetic engineering using site-specific nucleases was recently established in hPSCs ([@bib6; @bib13; @bib14; @bib46; @bib47]), allowing a level of genetic control that was previously limited to model systems. We can now target gene knockouts, generate tissue-specific cell lineage reporters, overexpress genes from a defined locus, and introduce or repair single-point mutations in hPSCs. Realizing the full potential of hPSCs will require robust differentiation protocols. Most current protocols isolate individual cell types rather than establish functional tissues. Although the former methods can identify cell-autonomous phenotypes, the study of cell-nonautonomous disease mechanisms necessitates a defined tissue context in which individual cell types are represented with the same stoichiometry and architecture as occur in vivo. The recent establishment of human intestinal tissue as in vitro organoid cultures from hPSCs and primary tissue represents a major advance toward creating such a model system for human tissue ([@bib15; @bib21; @bib25; @bib29; @bib31; @bib38]). Intestinal organoid cultures comprise tissue-specific differentiated cell types and adult stem-like progenitor cells that self-renew and differentiate, by growth factor induction, into the respective cell types of the intestinal epithelium. Here, we establish a protocol that can enrich for intestinal cells with adult stem character. We first generated an hESC line using gene editing that specifically labeled intestinal adult stem cells using a fluorescent reporter placed into an endogenous gene, and then used this cell line to identify and isolate adult stem cells from a pool of heterogeneous cell types during the differentiation of hPSCs.

We focused on a member of the [l]{.ul}eucine-rich repeat-containing [G]{.ul} protein-coupled [r]{.ul}eceptor (LGR) protein class, LGR5 ([@bib22]). LGR5 functions within the Wingless-related integration site (WNT) signaling cascade, which maintains the adult intestinal stem cell compartment ([@bib5]). LGR5 is activated by its ligand, R-spondin (RSPO1) ([@bib4; @bib5; @bib17; @bib28]), and has been shown by genetic lineage tracing experiments to mark intestinal stem cells ([@bib2]). LGR5-expressing cells at the base of the intestinal crypt exhibit WNT-dependent self-renewal and can differentiate into all cell types of the adult intestine ([@bib35]). Together, LGR5-expressing cells and Paneth cells form the adult stem cell niche and are sufficient to establish in vitro organoid cultures from mice ([@bib31]). Such murine in vitro organoids can be maintained over time in 3D Matrigel cultures under defined conditions that support either WNT-dependent self-renewal of adult stem cells or differentiation by the withdrawal of WNT and Notch signaling ([@bib18; @bib26; @bib41]). Similarly, human organoid cultures lacking stromal components can be derived from primary tissue biopsies when supplemented with additional small-molecule signals ([@bib15; @bib29; @bib30]), and in vitro hPSC-derived organoids can be maintained under a variety of conditions ([@bib15; @bib21; @bib30; @bib38; @bib43]) and used in human disease modeling ([@bib7]). Importantly, LGR5-positive mouse colon cells can form organoids that can be expanded ex vivo and allogenically transplanted into colitis models ([@bib10; @bib45]), suggesting that human intestinal tissue might be amenable to transplantation therapies.

Here, we report tools that allow for the isolation of adult intestinal stem cells and intestinal organoid cultures from direct differentiation of hPSCs using standard teratoma differentiation assays. Cultures with posterior gut qualities and expression profiles closely resembling those of human intestinal tissue can be derived and progressively enriched. Our strategy is based on direct isolation of LGR5-positive intestinal cells, a cell type that is only acquired over extended periods by other protocols ([@bib3; @bib21; @bib24; @bib38; @bib42]). Functional analysis and mRNA expression profiling of these organoid cultures confirmed the presence of a subset of adult stem cells. We expect that genetically engineering the parent hPSCs of an in vitro human intestinal tissue will provide a model for investigating human intestinal pathophysiology.

Results {#sec2}
=======

Genome Editing the Endogenous Human LGR5 Locus in hPSCs to Isolate Adult Intestinal Stem Cells {#sec2.1}
----------------------------------------------------------------------------------------------

Based on previous studies that used LGR5 expression to identify ([@bib2]) and isolate ([@bib31]) adult intestinal stem cells in mice, we tested whether a similar approach could be used to isolate and characterize gastrointestinal tissue derived from hPSCs. We developed two Zinc Finger Nuclease (ZFN) pairs that target the LGR5 gene in either the first (LGR5-GFP^N-term^) or last coding exon (LGR5-GFP^C-term^; [Figure 1](#fig1){ref-type="fig"}A; [Figure S1](#app3){ref-type="sec"}A available online). We coelectroporated these ZFNs and their corresponding donor plasmids into WIBR3 hESCs ([@bib20]) to integrate a GFP cassette together with a PGK-Puromycin into the LGR5 locus ([Figure 1](#fig1){ref-type="fig"}A). Southern blot analysis using external and internal probes ([Figures S1](#app3){ref-type="sec"}A and S1B) and sequence analysis in subsequent RNA sequencing (RNA-seq) confirmed the correct junction of the LGR5 gene with the GFP reading frame at either position. The targeting efficiencies for the generation of LGR5-GFP^N-term^ and LGR5-GFP^C-term^ cell lines were 18.75% and 6.25%, respectively.

Initially, we characterized this new LGR5 reporter system using a previously established protocol for the direct differentiation of hPSCs to intestinal cells ([@bib21; @bib38]; data not shown). In order to enrich more of the later steps of differentiation with increased LGR5 expression, we capitalized on our previous observation that in teratoma formation assays, some regions of the teratoma differentiate into intestinal-like tissues ([Figures 1](#fig1){ref-type="fig"}B, [S1](#app3){ref-type="sec"}C, and [S2](#app3){ref-type="sec"}D). When we performed these teratoma formation assays with the LGR5-GFP reporter cells, we were able to specifically detect GFP expression by immunohistochemistry (IHC) staining in regions that formed a polarized and specialized epithelium ([Figure 1](#fig1){ref-type="fig"}B). GFP expression was restricted to those intestinal tissues that uniformly stained positive for CDX2 and VIL1 ([Figures 1](#fig1){ref-type="fig"}B, [S1](#app3){ref-type="sec"}C, and S1D), and a subset of cells stained positive for intestinal markers mucin 2 (MUC2), lysozyme (LYZ), chromogranin A (CHGA), and at a lower frequency for PDX1 ([Figure 1](#fig1){ref-type="fig"}B, [S1](#app3){ref-type="sec"}C, and S1D). No significant GFP-positive staining in any other tissue type present in the teratoma, such as neuronal rosettes, cartilage, and smooth muscle, was detected ([Figure S1](#app3){ref-type="sec"}C). Further, we could only detect GFP-positive cells in teratomas derived from LGR5-GFP^N-term^ (n = 3) by IHC, and not in those derived from wild-type cells (n = 3) or LGR5-GFP^C-term^ cells (n = 3), although those cells did functionally sort by fluorescence-activated cell sorting (FACS). These observations may suggest a functional difference between the two reporter systems, or they may reflect differential stability, processing, or localization of the LGR5-GFP fusion protein.

Isolation of Intestinal Organoids from LGR5-GFP hPSCs {#sec2.2}
-----------------------------------------------------

The detection of LGR5-GFP-positive cells in teratomas prompted us to isolate these cells and test their ability to generate intestinal organoid cultures. We dissociated teratomas derived from LGR5-GFP hPSCs to a single-cell suspension and used FACS to isolate individual cells based on their GFP expression ([Tables 1](#tbl1){ref-type="table"}, top, and [S2](#app3){ref-type="sec"}B). LGR5-GFP-positive cells were embedded in Matrigel and cultured in conditions previously described for human intestinal organoid cultures ([@bib15; @bib30; @bib31; @bib38; @bib43]). Under these conditions, we observed multicellular epithelial structures with a central lumen after 3 days that proliferated into uniform, long-lived organoids with a morphology previously described for human intestinal organoids isolated from primary tissue ([@bib10; @bib15; @bib30]; [Figures 1](#fig1){ref-type="fig"}C, 1D, [S1](#app3){ref-type="sec"}E, and [S4](#app3){ref-type="sec"}A--S4D).

It is important to note that in independent experiments, these organoids were generated with high frequency from GFP-positive cells ([Table 1](#tbl1){ref-type="table"}, top), although they could also be robustly generated from nonsorted teratoma cells by enrichment through serial passage ([Figure 1](#fig1){ref-type="fig"}D). Undifferentiated hESCs ([Figure S4](#app3){ref-type="sec"}A) as well as the sorted GFP-negative fraction failed to give rise to organoids ([Table 1](#tbl1){ref-type="table"}, top), although this does not exclude the possibility that LGR5-negative cells could give rise to organoids under alternative conditions. The most prominent nonorganoid cells found to grow in the 3D matrix, regardless of whether the cells were GFP sorted or not, were single cells with neuronal precursor morphology. These contaminating cells were removed at each passage, enriching for nearly homogeneous long-term (\>150 days) organoid cultures that could be maintained regardless of whether they were derived from GFP-positive cells or from nonsorted teratomas ([Figures 1](#fig1){ref-type="fig"}C, 1D, and [S4](#app3){ref-type="sec"}A--S4D).

hPSC-Derived Intestinal Organoids Comprise All Major Cell Types of the Intestine {#sec2.3}
--------------------------------------------------------------------------------

To characterize hPSC-derived intestinal organoids, we performed quantitative RT-PCR (qRT-PCR) analysis of cultures derived from GFP-FACS experiments, as well as from nonsorted teratoma cells, followed by RNA-seq analysis of samples of tissues from different stages of our differentiation paradigm and primary intestinal biopsy-derived organoids ([Table S1](#app3){ref-type="sec"}). These analyses revealed the specific upregulation of intestinal stem cell markers such as LGR5, KLF5, and SOX9, and intestine-specific genes such as VIL1, MUC2, and TFF3 ([Figures S5](#app3){ref-type="sec"}E and S5F). Marker gene expression for FGF8 and other nonintestinal cell types such as Nestin and Sox1 (both neural) and MIXL1 (mesoderm) was significantly decreased in hPSC-derived intestinal organoids. Genes that were not associated with high intestinal stem cell expression showed low and variable expression levels in the GFP-sorted organoids, and pluripotency genes such as Nanog were absent. These data indicate that hESC-derived organoids were no longer pluripotent, had an intestinal expression pattern, and could be isolated without LGR5-GFP sorting ([Figures 2](#fig2){ref-type="fig"}, [S2](#app3){ref-type="sec"}A, and [S5](#app3){ref-type="sec"}F). Organoid cultures failed to form tumors when injected subcutaneously into immunocompromised mice (data not shown).

We found a nearly identical expression profile between organoid cultures that had been generated using either the LGR5-GFP marker or unsorted teratoma cells, suggesting that our culture method was selective for intestinal stem/progenitor cells, and that although the LGR5-GFP reporter was functional, it was dispensable for isolating intestinal organoid cultures by this method. These observations indicate that our protocol may be generalized to other genetically engineered hPSCs without the LGR5 reporter.

The major differentiated cell types of the intestinal epithelium include Paneth cells, enterocytes, goblet cells, and enteroendocrine cells. We asked whether these cell types could also be detected in our hPSC-derived intestinal organoids. IHC analysis showed that the hPSC-derived organoids comprise a mostly polarized epithelium that includes differentiated cell types with distinct morphologies and specific marker gene expression ([Figure 3](#fig3){ref-type="fig"}). We identified cells with robust expression of CHGA, a marker for enteroendocrine cells; MUC2, a marker for goblet cells; and VIL1, which marks the villi of enterocytes ([Figure 3](#fig3){ref-type="fig"}). Furthermore, we observed a subset of organoids containing cells that were enriched for lysozyme staining ([Figure S3](#app3){ref-type="sec"}; [Movie S1](#mmc3){ref-type="supplementary-material"}).

The expression of adult intestinal marker proteins for the major cell types of the adult intestinal tissue prompted us to further analyze the composition and subcellular organization of hESC-derived organoids by electron microscopy (EM). Micrographs showed that organoids were organized in a polarized epithelium, with nuclei positioned proximal to the basolateral membrane ([Figure 4](#fig4){ref-type="fig"}A). The apical cellular membranes were characteristic of enterocytes with highly organized microvilli ([Figures 4](#fig4){ref-type="fig"}B-II and 4D-III) and tight junctions connecting neighboring enterocyte-like cells ([Figures 4](#fig4){ref-type="fig"}B-I and 4D-III). Goblet-shaped secretory cells ([Figure 4](#fig4){ref-type="fig"}C) that contained large vesicles coming from a well-defined rough endoplasmic reticulum ([Figures 4](#fig4){ref-type="fig"}D-I and 4D-II) were embedded in the enterocytes. Vesicles of these cells were localized at the apical side of the cell, suggesting secretion toward the lumen of the organoid ([Figure 4](#fig4){ref-type="fig"}).

hPSC-Derived Intestinal Organoids Contain Cells with Characteristics of Adult Intestinal Stem Cells {#sec2.4}
---------------------------------------------------------------------------------------------------

Adult stem cells have the ability to self-renew and a restricted capacity to differentiate into defined cell types. The human intestinal epithelium is a highly proliferative tissue with a turnover rate of ∼5 days in differentiated cells outside the crypt. We found that single-cell-derived intestinal organoids could be maintained in long-term cultures (\>6 months), suggesting the presence of a self-renewing cell population. To further test for the presence of such adult stem cell-like cells, we assayed for the minimum growth factors required to establish and maintain the organoid cultures. As expected for a system that originates from adult intestinal stem cells, we found a phenotypic growth dependence on epidermal growth factor (EGF), Noggin, and RSPO1 (ENR; [Figures 5](#fig5){ref-type="fig"}A and 5B), factors that are also essential in the mouse organoid system and human primary cultures ([@bib2; @bib29; @bib38]). Alternative conditions that were previously reported to support human organoid cultures ([@bib15; @bib21; @bib38; @bib43]) also allowed us to derive organoids from teratoma samples with a morphology similar to that described in previous studies ([@bib8; @bib29; @bib39] [Figures S4](#app3){ref-type="sec"}B and S4C).

To further validate the presence of cells with adult stem cell-like characteristics in hPSC-derived intestinal organoids, we took advantage of the LGR5-GFP reporter system. First, we isolated organoid cultures from LGR5-GFP-derived teratomas without FACS sorting for GFP. After maintaining these cells for 5 days in 3D cultures, we investigated whether LGR5-GFP-positive cells were still present and able to form organoids after single-cell dissociation. We found that sorting for GFP fluorescence enriched for cells competent to form organoids when compared with the GFP-negative cell fraction ([Table 1](#tbl1){ref-type="table"}). Since LGR5 in mice marks intestinal stem, but not differentiated, cell types, this finding suggested that our culture conditions maintained cells with adult stem cell properties sufficient to form new organoids from single cells ([Table 1](#tbl1){ref-type="table"}; [Figures 1](#fig1){ref-type="fig"}D and [S1](#app3){ref-type="sec"}).

To further substantiate the presence of functional adult stem cell-like cells in the hPSC-derived organoid system, we cultured hPSC-derived organoids under conditions known to either promote self-renewal (high WNT signaling) or induce differentiation (Notch inhibition) of intestinal stem cells. We found that reduced WNT signaling by withdrawal of either WNT or RSPO1 reduced proliferation and decreased expression of the stem cell markers LGR5 and OLFM4 ([Figures 5](#fig5){ref-type="fig"}C and 5D), and induced differentiation into secretory cells as indicated by a shift in cellular morphology detected by EM and immunofluorescence (IF) staining ([Figure 5](#fig5){ref-type="fig"}E and 5F). These cells showed an increased number of vesicles at the apical/luminal border ([Figure 5](#fig5){ref-type="fig"}E), maintained CDX2, increased MUC2, and a density of filamentous actin at the apical border by IF ([Figures 4](#fig4){ref-type="fig"}, [5](#fig5 fig5){ref-type="fig"}E, and 5F).

Long-term maintenance of adult stem cells requires telomerase expression and enzymatic activity ([@bib11]). Telomerase activity in the human intestine is restricted to the stem cell compartment and is silenced upon differentiation of these cells ([@bib32]). We found that hPSC-derived organoid cultures could be maintained for several months, suggesting the presence of a self-renewing cell type. To functionally test whether hPSC-derived organoids contained telomerase-positive cells, we measured telomerase in vitro. As a positive control, we confirmed that the high level of telomerase activity in hESCs was significantly downregulated upon differentiation into fibroblast-like cells ([Figure 5](#fig5){ref-type="fig"}G). Notably, we could detect robust telomerase activity in three out of four independently derived intestinal organoid cultures when grown under adult stem cell conditions by telomeric repeat amplification protocol (TRAP) assay ([@bib16]; [Figure 5](#fig5){ref-type="fig"}G). However, this activity was abrogated upon terminal differentiation of organoids by WNT-signaling withdrawal and inhibition of γ-secretase by DAPT. These functional data suggest that cells with adult stem cell properties, such as self-renewal and multipotency, represent a subpopulation of organoid cells that can respond appropriately to differentiation cues.

hPSC-Derived Intestinal Tissue Organoids Are Closely Related to Human Primary Intestinal Tissue-Derived Organoids {#sec2.5}
-----------------------------------------------------------------------------------------------------------------

To determine the degree to which hPSC-derived organoids could recapitulate primary cultures established from adult intestinal tissue, we evaluated the expression profile using next-generation RNA-seq of hPSC-derived intestinal organoids cultured in media that either supported stem cell maintenance (n = 10) or induced terminal differentiation (n = 4). We compared these organoids with the parent hESC lines (n = 4) and teratoma samples (n = 4), and with organoids generated from adult human tissue samples biopsied from the duodenum (n = 2), ileum (n = 2), or rectum (n = 2). Unbiased complete linkage clustering for the top 5,000 most differentially expressed transcripts across these samples revealed that hESC-derived organoids closely resembled organoids isolated from the intestines of human subjects ([Figures 6](#fig6){ref-type="fig"}A and [S5](#app3){ref-type="sec"}A). In contrast, teratoma samples were most similar to hESCs ([Figures 6](#fig6){ref-type="fig"}A, [S5](#app3){ref-type="sec"}A, and S5C). Transcriptional profiling of organoids derived from an independent hESC line (BG01) confirmed that organoids could be derived irrespective of the genetic background of the hPSC cell line with high similarity to primary tissue-derived organoids ([Figures 6](#fig6){ref-type="fig"}A, 6B, and [S5](#app3){ref-type="sec"}A--S5D). hESC-derived intestinal organoids grown in WENR (Wnt3a, EGF, Noggin, R-spondin-1) media expressed levels of intestinal adult stem cell marker genes (LGR5, OLFM4, KLF4, KLF5, SOX9, and TERT) and differentiated/secretory linage genes (e.g., KRT20, VIL1, MUC2, LYZ, CA2, SI, and PLA2GA) analogous to those found in organoids derived from primary tissue, with the greatest similarity to rectum-derived samples ([Figures 6](#fig6){ref-type="fig"}B, 6E, and [S5](#app3){ref-type="sec"}D--S5G).

In contrast to previous results obtained by established protocols, our intestinal organoids did not result in a significant budding of crypt-like structures, which are characteristic of mouse small intestine cultures. The cystic morphology of our organoids was previously described for developmental immature stages of enterosphere differentiation, as well as for adult colon-derived organoids ([@bib10; @bib15; @bib29; @bib39]). Whereas the expression levels of several marker proteins for intestinal function, such as PLAG2A, TFF1, and TFF2 ([Figures S5](#app3){ref-type="sec"}D--S5F) offer evidence of cell maturation of hESC-derived organoids, the full complexity of intestinal maturation was not recapitulated by this in vitro culture. The complex maturation signals required from the neural and vascular plexus and the mesenchyme have yet to be defined in an in vitro culture ([@bib44]). Nevertheless, our protocol results in organoids that express adult stem cell markers to the same extent as primary tissue-derived organoids, suggesting that they are beyond a developmental stage that was recently described for human embryonic-like intestinal progenitor cells ([@bib10]; [Figures S5](#app3){ref-type="sec"}B and S5D--S5F).

Next, we attempted to address the positional identity of these organoids with respect to anterior/posterior gut development. We found expression of the caudal-type homeobox gene CDX1 and the hindgut markers CDX2 ([@bib34]) PLA2G2A, CA2, and MUC2 in hPSC-derived organoids and in rectum-derived tissues ([Figures 6](#fig6){ref-type="fig"}, [S5](#app3){ref-type="sec"}D, and S5E). The midgut gene PDX1 was enriched in duodenal-derived samples only, and organoids expressed levels more comparable to the distal gut (ileum/rectum; [Figure 6](#fig6){ref-type="fig"}B). This analysis suggests that our differentiation protocol may bias for relatively mature hindgut/large intestinal-like tissue.

To further substantiate that hESC-derived organoids specifically express intestinal adult stem cell markers, we analyzed the expression profile of the LGR5-GFP reporter gene in hESC-derived organoids by RNA-seq. Here we found that both the LGR5-GFP^N-term^ and LGR5-GFP^C-term^ reporter recapitulated the expression of the endogenous LGR5 gene and contained a sequence that aligned across the expected fusion junction by RNA-seq ([Figures 1](#fig1){ref-type="fig"}A and [6](#fig6){ref-type="fig"}C). Although the LGR5 reporter was expressed in hESCs and slightly reduced in teratoma cells, it was higher in the bulk analysis of organoids that were maintained under stem cell conditions. Importantly, LGR5-GFP expression was significantly repressed in organoid cultures under differentiation conditions ([Figure 6](#fig6){ref-type="fig"}C). These data not only validate our LGR5-GFP reporter systems, even though they showed minimal fluorescence by microscopy, but also support the hypothesis that a defined organoid system containing adult stem cells can be successfully generated from hPSCs by this method. Furthermore, a Gene Ontology analysis for genes that were differentially expressed between hESCs (n = 4) and hESC-derived intestinal organoids (n = 10) revealed a significant enrichment of genes associated with the gastrointestinal system ([Figure 6](#fig6){ref-type="fig"}D). Categories that were enriched included *Epithelial Differentiation* and *Digestion* for biological processes, and various *Peptidase Activities* for biological function. We also analyzed the genes that were differentially expressed between the human primary-derived samples and the hESC-derived organoids (see [Supplemental Experimental Procedures](#app3){ref-type="sec"} for further discussion of the RNA-seq data).

Finally, we analyzed independently derived organoid cultures that were grown in the absence of WNT3a and in the presence of DAPT. Transcriptional changes showed that this specific change in WNT and Notch signaling resulted in the induction of intestinal-specific differentiation markers and a reduction of adult intestinal stem cell markers ([Figures 6](#fig6){ref-type="fig"}E and [S5](#app3){ref-type="sec"}D).

In summary, our genome-wide expression analysis confirmed the following hypotheses: (1) organoids are similar to primary intestinal tissue, specifically the large intestine; (2) organoids express adult intestinal stem cell markers such as SOX9, OLFM4, KLF4, KLF5, LGR5, and TERT; (3) the genes expressed indicate that organoid cultures comprise a relatively mature hindgut-like tissue; (4) expression of LGR5 and the LGR5-GFP reporter is upregulated in mature organoids; and (5) organoids respond to the canonical cues that also determine differentiation and self-renewal in the intestine of adult humans.

Discussion {#sec3}
==========

A Human LGR5-GFP Reporter System Allows the Isolation of Intestinal Tissue Organoids {#sec3.1}
------------------------------------------------------------------------------------

Here, we report on the development of a method that allows robust derivation of human intestinal adult stem cells and organoid tissue from hPSCs. We used ZFN-mediated genome editing of the endogenous LGR5 locus to generate a reporter system based on a previous study in mice that established LGR5 as a bona fide marker of adult intestinal stem cells ([@bib2]). Analogous to what was observed in previous mouse experiments, we demonstrate here that generating either an N- or C-terminal reporter of human LGR5 allows the specific isolation and enrichment of cells with the ability to form organoid cultures from hPSCs despite showing minimal fluorescence by microscopy. Our results provide proof of concept for using site-specific gene-editing technology to isolate novel human cell types from hPSCs.

The intestinal organoids that we generated are similar to tissue isolated directly from humans, as they express gastrointestinal-specific genes and contain highly organized and differentiated cell types such as goblet-, enterocyte-, and enteroendocrine-like cells. In addition to the tissue organization, the cellular and subcellular morphology of hESC-derived organoids is reminiscent of primary organoid cultures. When grown under conditions that promote differentiation, organoids consist of an epithelial sheet of polarized cells with a subcellular organization characteristic of specific cell subtypes, such as secretory cells. Expression profiling suggests that our differentiation protocol may bias for relatively mature hindgut/large intestinal-like tissue. We do not know if this is an intrinsic feature of the teratoma or a function of our culture conditions. However, we find that a subset of organoids contain cells that stain positive for the small-intestine marker gene lysozyme, suggesting that our protocol does not strictly discriminate against more anterior regions of the intestine. As we can detect lysozyme- and PDX1-positive cells in the parent teratoma samples, it seems possible that our method could also be refined to specifically isolate and enrich for small-intestine cellular subtypes.

Modeling Intestinal Function and Disease Using hESC-Derived Intestinal Tissue {#sec3.2}
-----------------------------------------------------------------------------

For many research applications, including nutrient uptake, drug delivery, metabolic regulation, and human disease modeling (e.g., intestinal cancer), rodent models do not fully recapitulate human intestinal physiology. However, organoids derived from hPSCs may provide a novel platform for in vitro disease modeling and drug screening to complement experiments in conventional animal models.

The organoid system established here will advance disease modeling because the differentiation protocol does not rely on the LGR5 reporter and because the committed intestinal stem cells can be derived from hiPSCs and hESCs. We demonstrate that hESCs that are genetically engineered by TALEN and ZFN-mediated genome editing can subsequently be used to generate intestinal organoids, suggesting that genome-editing approaches such as ZFN, TALEN, and CRISPR-mediated gene knockout and transgenesis will facilitate the study of intestinal biology. Gene editing will allow the generation of isogenic disease-specific cell lines, circumventing the problem of heterogeneity in human samples and eliminating the phenotypic heterogeneity of in vitro phenotypes ([@bib36; @bib37]), thereby complementing current approaches that directly genetically modify intestinal organoid cultures ([@bib23; @bib33]).

hESC-Derived Organoids Represent a Novel In Vitro Adult Stem Cell System {#sec3.3}
------------------------------------------------------------------------

Adult intestinal stem cells are a highly specialized and differentiated cell type that is formed through a well-timed and coordinated developmental process. Our isolation procedure for hPSC-derived intestinal adult stem cells suggests that these developmental cues can be sufficiently recapitulated when hPSCs form a teratoma. Key features of the differentiation process during teratoma formation that may allow for the establishment of adult stem cells include the extended period of time in which the tissue is allowed to form without perturbation, the optimal nutrient/hormonal conditions, and the unconstrained 3D growth in the subcutaneous compartment. In the future, these particular characteristics will have to be recapitulated in a xeno-free differentiation paradigm. Considering that LGR5 has recently also been implicated in adult stem cell function and maintenance of other tissue types, it will be interesting to investigate whether this strategy of genetically engineering hPSCs to carry reporter genes can be applied to the culture of other adult stem cell types that previously could not be isolated.

Experimental Procedures {#sec4}
=======================

Teratoma Formation and Analysis {#sec4.1}
-------------------------------

hESCs were collected by collagenase treatment (1.5 mg/ml) and separated from feeder cells by sedimentation. Cells were resuspended in 250 μl of PBS and injected subcutaneously into NOD-SCID mice (Taconic). All animal protocols were approved by the ACUC of UC Berkeley. Tumors (\<1.5 cm) formed within 4--8 weeks, at which time teratomas were isolated and disaggregated to single cells or fixed in formalin for analysis of hematoxylin and eosin (H&E) staining. Immunostaining of paraffin sections was performed with standard techniques using a rabbit polyclonal anti-GFP antibody (Abcam 290).

Culture of Intestinal Epithelial Organoids from hESCs {#sec4.2}
-----------------------------------------------------

Single cells isolated from teratomas were embedded at 4°C in 50 μl Matrigel containing 1 μM JAG-1 (No. 61298; AnaSpec) and incubated at 37°C for 10 min. The medium (500 μl/well) consisted of 1:1 Dulbecco's modified Eagle's medium F-12 and Neurobasic with N2, B27, L-glutamine, nonessential amino acids, penicillin/streptomycin, and growth factors WNT3A (200 ng ml^−1^), RSPO1 (1 μg ml^−1^), EGF (50 ng ml^−1^), Noggin (100 ng ml^−1^), and ROCK inhibitor (10 μM), and was changed every 2 days. Organoids were passaged using 5 min dispase digestion, subcultured, and gravity separated from single cells using a PBS 0.5% BSA wash. After a 5 min incubation in PBS, 0.5% BSA, and 2 mM EDTA, and hESC media inactivation, the tissue was pelleted and resuspended in 4°C Matrigel as described above. When indicated, WNT was withdrawn and 10 μM DAPT was added to the cultures for 4 days to induce differentiation.

Human Subject Tissues {#sec4.3}
---------------------

The ethics committee of the University Medical Centre Utrecht approved this study and written informed consent was obtained from the human subjects. Organoids were generated from biopsies obtained for diagnostic purposes and maintained in culture (for 1--6 months) as described previously ([@bib30]).

IF Staining {#sec4.4}
-----------

Organoids were fixed in 3% paraformaldehyde with 5% sucrose in PBS (pH 7.4) for 30 min. Samples were embedded for cryosectioning, sectioned at 10 μM, and mounted on poly-L-lysine-coated slides. Samples were permeabilized with TBST (Tris-buffered saline with 0.5% Triton X-100) and incubated at 4°C, 1:5,000 dilution, with shaking overnight. The slides were washed three times with TBST at 4°C and then incubated with the appropriate Alexa Fluor secondary antibodies (1:1,000) and a phalloidin conjugate (1:1,000). Afterward, the slides were washed as before, stained for DAPI, and mounted.

Transcriptional Profiling {#sec4.5}
-------------------------

Details regarding the protocol used for transcriptional profiling are provided in [Supplemental Experimental Procedures](#app3){ref-type="sec"}. Briefly, an RNA-seq library was created using the standard Illumina library preparation protocol. Ribosomal RNAs were depleted using a oligo(dT) 25 magnetic bead kit (Life Technologies), and the libraries were generated using the PrepX SPIA RNA-Seq and PrepX Library kit (IntegenX) according to the manufacturer's protocol. Reads were mapped to the Ensembl cDNA release 72 ([@bib9]) with Bowtie2 version 2.1.0 ([@bib19]) using the parameters --rdg 6,5, --rfg 6,5, and --score-min L,-.6,-.4. Transcript abundances were calculated with eXpress version 1.4.0 ([@bib27]) and the resulting effective counts for each transcript were used to calculate fold changes. Effective counts were also processed with DESeq version 1.12.0 ([@bib1]) to identify statistically significant differentially expressed genes and transcripts. Fragments per kilobase of transcript per million mapped reads (FPKM) results are available in [Supplemental Experimental Procedures](#app3){ref-type="sec"} and the raw data for RNA-seq are available at <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE56930>.

Additional details regarding the methods used in this work can be found in [Supplemental Experimental Procedures](#app3){ref-type="sec"}.

Accession Numbers {#app1}
=================

The GEO accession number for the RNA-seq data reported in this paper is [GSE56930](ncbi-geo:GSE56930){#intref0015}.

Supplemental Information {#app3}
========================
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![Generation of LGR5-GFP Reporter hESCs Using ZFNs\
(A) Schematic overview depicting the gene-editing strategy for the LGR5 locus using a ZFN targeted to either the first or last coding exon of LGR5. Southern blot probes are shown as red boxes, exons are shown as blue boxes. Below are the donor plasmids used to target the LGR5 locus to generate either an N-terminal (LGR5-GFP^N-term^) or a C-terminal (LGR5-GFP^C-term^) LGR5-GFP reporter. pA, polyadenylation sequence; PGK, phosphoglycerate kinase promoter; Puro, puromycin resistance gene; eGFP, enhanced green fluorescent protein. Shown below the donor plasmids is the LGR5 locus after targeting with the respective donor plasmids.\
(B) IHC staining for indicated proteins in teratoma sections derived from LGR5-GFP^N-term^ hESC reporter cells. MUC2, mucin2; VIL1, villin1; CHGA, chromogranin A; CDX2, caudal type homeobox 2; LYZ, lysozyme; PDX1, pancreatic and duodenal homeobox 1.\
(C) Phase contrast and H&E staining of epithelial organoid cultures arising from LGR5-GFP sorting experiments. See quantification in [Table 1](#tbl1){ref-type="table"}.\
(D) Bright-field images of developing organoids (outlined by yellow lines) derived from nonsorted single-cell suspensions after Matrigel embedding. The demarcation outlined by white lines in bright-field images taken on days 5^∗^--15 was used as a reference point for tracking organoids clustered near this region. Cells were passaged every 5 days; here, an image before and after (^∗^) passaging is shown. All bars, 200 μm.\
See also [Figure S1](#app3){ref-type="sec"}.](gr1){#fig1}

![Isolation of Intestinal Organoids Independent of the LGR5-GFP Reporter System\
Expression profiling of organoids from GFP-positive and nonsorted LGR5-GFP teratoma cells compared with hESCs and fibroblast-like cells. qRT-PCR for the indicated genes in hESCs, organoids derived from eGFP-positive cells (n = 3), and nonsorted (n = 3) cells of LGR5-GFP^N-term^, hESCs, and fibroblast-like cells (derived from hESCs as described previously \[[@bib12]\], expressing telomerase from the AAVS1 locus). Relative expression levels were normalized to baseline expression of these genes in hESCs. Data are biological replicates of independent experiments; bars represent the SEM. See also [Figure S2](#app3){ref-type="sec"}.](gr2){#fig2}

![hESC-Derived Organoids Comprise Specific Cell Types Characteristic of the Human Intestinal Epithelium\
(A) IHC staining for intestinal marker proteins in sections of hESC-derived organoids generated from wild-type hESC reporter cells. ECAD1, E-cadherin; FABP1, fatty acid-binding protein 1; EPCAM, epithelial cell adhesion molecule; MUC2, mucin2; CHGA, chromogranin A; VIL1, villin1.\
See also [Figure S3](#app3){ref-type="sec"}.](gr3){#fig3}

![Subcellular Organization of Organoids Resembles the Structure of the Human Intestinal Epithelium\
(A) Electron micrograph of hESC-derived organoids. Shown is a representative image with enterocyte-like cells forming a polarized epithelium. The lumen of the organoid is oriented to the left (apical), while the nuclei are aligned along the right (basal).\
(B) Higher-magnification images of the micrograph shown in (A). Insets indicate areas of increased magnification. Images show the microvilli lining the luminal cell surface, vesicles in the luminal space (II), and the tight junctions connecting adjacent enterocyte-like cells (I).\
(C) Electron micrograph of hESC-derived organoids. Shown is a representative image of a goblet-like secretory cell that is embedded into a sheet of enterocyte-like cells. Orientation of the image as in (A).\
(D) Higher-magnification images of the micrograph shown in (C). Insets indicate areas of increased magnification. Images show magnification of vesicles (I), rough endoplasmic reticulum at the base of the vesicles (II), and tight junctions and cellular debris shed into the organoid's lumen (III).](gr4){#fig4}

![WNT and Notch Signaling Is Required to Establish and Maintain Cells with Adult Stem Cell Properties in hESC-Derived Intestinal Organoids\
(A) Bright-field image of organoids at day 5 of their derivation under the indicated culture conditions at two different magnifications. Growth factors (GFs) : WENR \[W, Wnt3a; E, EGF; N, Noggin; R, R-spondin-1\] were supplemented in the combinations indicated. No GFs were added to "base media."\
(B) Quantification of images shown in (A). The graph shows the number of organoids larger than 150 μm from a single teratoma isolation cultured in parallel under the conditions described in (A), where organoids were grown in 50 μl solidified Matrigel in 500 μl media/well in a 24-well plate.\
(C) Bright-field image of organoids at day 15. The image to the left shows a culture at day 15 when grown in WENR, and the right image shows the same cells when switched at day 10 to differentiation media.\
(D) qRT-PCR for the intestinal stem cell markers LGR5 and OLFM4 in a single organoid culture treated in parallel with different culture conditions. The ‡ symbol indicates 1,000 ng/ml and 200 ng/ml of RSPO1 and WNT3a, respectively, and + indicates 200 μg/ml and 50 ng/ml of RSPO1 and WNT3a, respectively. Where indicated, DAPT was added at 10 μM.\
(E) Electron micrographs of the cells shown in (C). Size bars indicate 2 μm.\
(F) IF staining of cryosectioned organoids cultured in either stem cell media (WENR) or differentiation media (10 μM ENR+DAPT added for 4 consecutive days). Top: MUC2 (green), phalloidin (red), and DAPI (blue). Bottom: CDX2 (red), phalloidin (green), and DAPI (blue).\
(G) TRAP assay ([@bib16]) of hESCs, hESCs differentiated into fibroblast-like cells ([@bib12]), intestinal organoids grown in stem cell media (WENR, n = 2) or differentiation media (10 μm ENR+ DAPT, n = 2). Shown is a ^32^P autoradiogram of TRAP activity described for decreasing amounts of protein extracts (1.0--0.4 μg) for the indicated cell types (hESCs \[WIBR3\]; Fibro., fibroblast-like cells derived from WIBR3).\
See also [Figure S4](#app3){ref-type="sec"}.](gr5){#fig5}

![hESC-Derived Organoids Share a Transcriptional Profile with Primary Intestinal Tissue-Derived Organoids and Display the Characteristic Responses to Differentiation Stimuli\
(A) Cluster analysis of hESCs (n = 4), teratoma samples (n = 4), bulk hESC-derived organoid cultures grown in WENR (n = 10), bulk cultures of hESC-derived organoids grown in differentiation medium (ENR+DAPT, n = 4), and primary duodenum- (n = 2), rectum- (n = 2) and ileum- (n = 2) derived organoids. Euclidian distances calculated from the abundance levels of the top 5,000 differentially expressed transcripts are also shown in [Figure S1](#app3){ref-type="sec"}A.\
(B) Heatmap displaying an unbiased cluster analysis of samples analyzed in (A) for a limited selection of genes relevant to intestinal expression and, in most cases, reported functions. Shown are the Euclidian distances calculated from the relative expression of the genes as determined by next-generation RNA-seq expression analysis.\
(C) Density maps of RNA-seq reads mapped to the genetically engineered LGR5-GFP^N-term^ and LGR5-GFP^C-term^ locus. The top boxes show the predicted transcripts for each allele based on validated gene editing described in [Figure 1](#fig1){ref-type="fig"}A. Shaded in green is the region mapping to the coding sequence for the eGPF fusion reporter. Shown across each histogram are the alignments to Lgr5-eGFP fusions predicted for each cell line. RNA was collected from the parent hESC cell lines, the intermediate teratoma samples, intestinal organoids, and intestinal organoids differentiated by the withdrawal of WNT3a and the addition of DAPT.\
(D) Gene Ontology analysis for tissue-specific expression using the Database for Annotation, Visualization and Integrated Discovery (DAVID; <http://david.abcc.ncifcrf.gov/home.jsp>) and the "UNIGENE_EST_QUARTILE" expression profile database. Analyzed were genes significantly (FDR corrected p value \< 0.05) unregulated (\>2^2.5^-fold) in hESC-derived intestinal organoids (n = 10) compared with hESCs (n = 4).\
(E) Heatmap displaying an unbiased cluster analysis of organoid samples (from groups 1, 2, 6, and 7 as described in [Table S1](#app3){ref-type="sec"}) analyzed in (A) for selected genes that are associated with the differentiation of adult intestinal stem cells. Shown are pairwise hESC-derived intestinal organoid cultures (n = 4) grown in either WENR stem cell media (S) or differentiated in ENR+DAPT (D).\
See also [Figure S5](#app3){ref-type="sec"}.](gr6){#fig6}

  WIBR3-hESC Derived                                                                                                                                                                                                                                                                                   
  ------------------------------------------------------------------- --------------------------------- ----------------------------- ------------------------- --------------------------------- ----------------------------- ------------------------- --------------------------------- ---------- --------
  Lgr5-GFP N-term                                                     0                                 1,000                         0                         23                                1,000                         2.3                       ∼50                               \>50,000   \<0.1%
  Lgr5-GFP N-term                                                     0                                 1,710                         0                         101                               1,710                         5.91                      ∼50                               \>50,000   \<0.1%
  Lgr5-GFP N-term                                                     0                                 1,675                         0                         21                                1,675                         1.25                      ∼50                               \>50,000   \<0.1%
  Lgr5-GFP C-term                                                     0                                 4,203                         0                         38                                4,203                         0.9                       ∼50                               \>50,000   \<0.1%
  Lgr5-GFP C-term                                                     0                                 6,613                         0                         81                                6,613                         1.22                      ∼50                               \>50,000   \<0.1%
  Lgr5-GFP N-term                                                     0                                 6,046                         0                         3                                 6,046                         0.05                      ∼50                               \>50,000   \<0.1%
                                                                                                                                                                                                                                                                                                       
  **Organoid-rederived organoids**[b](#tblfn2){ref-type="table-fn"}                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                       
  **Organoids**                                                       **No. of organoids formed**       **GFP Negative**              **GFP Positive**          **Total**                                                                                                                              
                                                                                                                                                                                                                                                                                                       
  **No. of cells sorted**                                             **Cells forming organoids (%)**   **No. of organoids formed**   **No. of cells sorted**   **Cells forming organoids (%)**   **No. of organoids formed**   **No. of cells sorted**   **Cells forming organoids (%)**              
                                                                                                                                                                                                                                                                                                       
  Lgr5-GFP N-term                                                     0                                 1,500                         0                         7                                 1,500                         0.47                      7                                 15,000     0.05
  Lgr5-GFP N-term                                                     24                                6,700                         0.36                      140                               6,700                         2.09                      65                                13,000     0.5
  Lgr5-GFP N-term                                                     3                                 7,960                         0.04                      20                                7,960                         0.26                      15                                38,450     0.04

Six independent teratomas FAC-sorted and assayed for organoid formation.

Three organoids derived from three independent unsorted teratomas (dissociated, FAC-sorted, and assayed for organoid formation).
